日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

  1. Home
  2. 抗體
  3. 科研級(jí)生物類似抗體
  4. TNFSF13 (Zigakibart Biosimilar) Recombinant Monoclonal Antibody

TNFSF13 (Zigakibart Biosimilar) Recombinant Monoclonal Antibody

  • 貨號(hào)：
    CSB-RA023989MB3HU
  • 規(guī)格：
    ￥83486
  • 其他：

產(chǎn)品詳情

  • 產(chǎn)品描述：
    TNFSF13(Zigakibart Biosimilar Antibody)重組單克隆抗體是一種針對(duì)腫瘤壞死因子超家族成員13（TNFSF13）的重組單克隆抗體，主要用于科研領(lǐng)域的基礎(chǔ)研究與機(jī)制探索。該抗體通過基因工程技術(shù)制備，具有高特異性和親和力，能夠精準(zhǔn)識(shí)別并結(jié)合TNFSF13蛋白，為研究其在生理與病理過程中的作用提供重要工具。 在免疫學(xué)研究中，TNFSF13作為關(guān)鍵的細(xì)胞因子，參與B淋巴細(xì)胞的活化、增殖與存活調(diào)控，同時(shí)在免疫調(diào)節(jié)、炎癥反應(yīng)及自身免疫性疾病的發(fā)生發(fā)展中扮演重要角色。通過使用TNFSF13重組單克隆抗體，科研人員可深入探究該因子與受體的相互作用機(jī)制，揭示其在免疫信號(hào)通路中的調(diào)控網(wǎng)絡(luò)，為相關(guān)疾病的發(fā)病機(jī)制研究提供實(shí)驗(yàn)依據(jù)。 此外，該抗體在藥物靶點(diǎn)驗(yàn)證、細(xì)胞模型構(gòu)建及蛋白質(zhì)相互作用研究等方面具有廣泛應(yīng)用價(jià)值。其高純度和批次穩(wěn)定性確保了實(shí)驗(yàn)結(jié)果的可靠性與可重復(fù)性，適用于多種實(shí)驗(yàn)技術(shù)。通過特異性阻斷TNFSF13的生物學(xué)活性，可幫助研究人員評(píng)估其在疾病模型中的功能，為開發(fā)新型治療策略提供理論基礎(chǔ)。 作為科研用試劑，TNFSF13重組單克隆抗體為生命科學(xué)領(lǐng)域的探索提供了有力支持，推動(dòng)免疫學(xué)、細(xì)胞生物學(xué)及相關(guān)疾病機(jī)制研究的深入發(fā)展。
  • Uniprot No.：
  • 基因名：
  • 別名：
    Anti-APRIL monoclonal antibody research-grade biosimilar; BION 1301 research-grade biosimilar; BION-1301 research-grade biosimilar; FUB523 research-grade biosimilar; FUB 523 research-grade biosimilar; FUB-523 research-grade biosimilar ;TNFSF13 antibody; APRIL antibody; TALL2 antibody; ZTNF2 antibody; UNQ383/PRO715 antibody; Tumor necrosis factor ligand superfamily member 13 antibody; A proliferation-inducing ligand antibody; APRIL antibody; TNF- and APOL-related leukocyte expressed ligand 2 antibody; TALL-2 antibody; TNF-related death ligand 1 antibody; TRDL-1 antibody; CD antigen CD256 antibody
  • 反應(yīng)種屬：
    Human
  • 免疫原：
    Recombinant Human TNFSF13 protein
  • 免疫原種屬：
    Homo sapiens (Human)
  • 標(biāo)記方式：
    Non-conjugated
  • 克隆類型：
    Monoclonal
  • 濃度：
    It differs from different batches. Please contact us to confirm it.
  • 保存緩沖液：
    0.01M PBS，pH7.4
  • 產(chǎn)品提供形式：
    Liquid
  • 應(yīng)用說明：
    Validation Status
    Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
    Guaranteed Quality
    ① Antibody purity?> 95% tested by SDS-PAGE.
    ② Endotoxin level < 0.1EU/ug tested by LAL method.
  • 儲(chǔ)存條件：
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期：
    3-4 weeks
  • 用途：
    It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.

產(chǎn)品評(píng)價(jià)

靶點(diǎn)詳情

  • 功能：
    Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. Plays a role in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
  • 基因功能參考文獻(xiàn)：
    1. TNFSF13, SPATC1L, SLC22A25 and SALL4 may thus be novel susceptibility loci for atrial fibrillation in the Japanese population PMID: 28849223
    2. The results suggest that increased levels of BAFF and APRIL produced in the central nervous system may influence the development of anti-neutrophil cytoplasmic antibody-hypertrophic pachymeningitis. PMID: 28847534
    3. The genetic variations and gene expression level of TNFSF13 are associated with the susceptibility and severity of IgA nephropathy in a Han Chinese population. PMID: 28636766
    4. APRIL levels are associated with disease activity in human chronic graft-versus-host disease. PMID: 26992945
    5. APRIL but not BLyS promotes IL-10 production by CpG-activated B cells and enhances the regulatory role of B cells on T cells. PMID: 27372914
    6. BCMA has other contributors for ligands binding except DxL motif. The affinity of BCMA for APRIL higher than for BAFF may be caused by the segment outside of the conservative DxL motif. Moreover, the exposition of new binding modes of BCMA2 interacting with APRIL may establish the foundation of designing novel drugs in the future PMID: 28260502
    7. APRIL transgenic mice infected by Helicobacter species may represent a novel animal model of gastric lymphomagenesis. PMID: 28460208
    8. ApoE-/-APRIL-Tg mice have increased oxLDL-specific serum IgM levels, potentially mediated via an increase in B1a lymphocytes PMID: 27820817
    9. Results showed that chemokine-mediated recruitment of neutrophils secreting the tumor-promoting factor APRIL mediates DLBCL progression. PMID: 27923834
    10. This study showed that both BAFF and APRIL levels were increased in CSF of patients with anti-NMDAR encephalitis. PMID: 28284352
    11. The results demonstrated that rs11552708 of the APRIL gene is not associated with Systemic lupus erythematosus (SLE) susceptibility in Iranian children. Likewise, these findings suggest that APRIL antagonist could be a potential therapeutic target to control SLE in children. PMID: 27878683
    12. New molecular mechanisms of in vivo Multiple Myeloma (MM) growth and immunosuppression critically dependent on BCMA and APRIL in the Bone marrow microenvironment, further supporting targeting this prominent pathway in MM. PMID: 27127303
    13. Urinary APRIL (uAPRIL) and BAFF (uBAFF) levels were raised significantly in AN. PMID: 27804111
    14. High expression of APRIL is associated with hepatocellular carcinoma. PMID: 28035399
    15. Data did not detect any significant association with SNPs of APRIL, SPATA8, PDGFRA, and POLB with Systemic Lupus Erythematosus in Chinese Han Population. PMID: 27569236
    16. Recombinant human APRIL (rhAPRIL) could rescue HCC cell proliferation inhibited by miR-383. PMID: 26385772
    17. high expression of APRIL in clear cell renal cell carcinoma was correlated with high Fuhrman nuclear grade, high pathologic stage, and poor overall and cancer-specific survival of the patients PMID: 26296917
    18. TNFSF13 and FDX1 have potential roles in IgAN in the Han Chinese population. This information may be useful in the development of early prognostics for IgAN. PMID: 26431901
    19. Did not find any positive association between TNFSF13 SNPs and the risk of IgA nephropathy after adjustment for age and sex, but did find a significant and strong correlation with relevant clinical pathological parameters. PMID: 26370181
    20. plasma level elevated in IgA nephropathy PMID: 26986150
    21. results indicate that analysis of serum concentrations of BAFF and APRIL potentially represents a useful tool for the assessment of AIHA disease activity and progression. PMID: 26243624
    22. Abnormal levels of BAFF/APRIL in pediatric acute lymphoblastic leukemia suggest that BAFF/APRIL are associated with the development and progression of this disease in children PMID: 26950089
    23. SNPs rs9514828 (BAFF), rs3803800 (APRIL) and rs4985726 (TACI) may be associated with the risk of development of B-cell chronic lymphocytic leukemia in a Polish population. PMID: 26268376
    24. Data show decrease of serum APRIL levels in diabetic patients with Type-1 Diabetes or Type-2 Diabetes suggesting suggest that APRIL can be considered as a potential modulating cytokine in the inflammatory process of diabetes. PMID: 26469782
    25. Surface APRIL is elevated in circulating myeloid cells in patients with rheumatoid arthritis, where it is highly correlated with disease activity. PMID: 25729037
    26. elevated serum levels in patients with Behcet's disease PMID: 25759827
    27. the elevated presence of APRIL and BLyS in B cell-rich areas of chronically inflamed gingiva suggests that these cytokines may contribute to bone loss by promoting the survival and persistence of RANKL-expressing B cells/plasma cells. PMID: 26150532
    28. Results show that APRIL was significantly up-regulated in gastric cancer and high levels of APRIL correlated with resistance to cisplatin through the activation of the canonical NF-kappaB pathway. PMID: 25612651
    29. APRIL could be a potential diagnosed marker to distinguish glottic malignant disease from glottic benign lesion, and it may play an important role in the development of glottic malignant disease. PMID: 24276470
    30. APRIL expression is correlated with malignant gastrointestinal stromal tumours phenotypes and it may serve as an unfavourable prognostic marker in patients with gastrointestinal stromal tumours PMID: 25393252
    31. High APRIL expression is associated with breast cancer. PMID: 25750171
    32. Data suggest that APRIL protein (a proliferation-inducing ligand) could be a potential biomarker for predicting difficult-to-treat cases of lupus nephritis. PMID: 23171638
    33. APRIL is increased in patients with active systemic lupus erythematosus. PMID: 24748505
    34. Enhanced APRIL levels are associated with acute lymphoblastic leukemia. PMID: 25582383
    35. A high APRIL serum level was significantly associated with decreased progression-free survival in follicular lymphoma patients. PMID: 25146008
    36. APRIL may participate in the formation of seropositive rheumatoid arthritis. PMID: 24898359
    37. Our results suggest that an elevated level of BAFF/APRIL drives the maturation of B cells, subsequently leading to IgA2 class switching, and possibly to the development of interstitial lung disease in patients with mixed connective tissue disease. PMID: 24252051
    38. BAFF and APRIL as well as their cognate receptors (BCMA, TACI) correlate with glioma grade. (Meta-analysis) PMID: 24376672
    39. Show a novel method to obtain soluble human APRIL in Escherichia coli using the elastin-like polypeptide and SUMO (ELP-SUMO) tags. PMID: 24412409
    40. The levels of APRIL correlate with the progression of childhood ALL, which may provide certain clues for monitoring ALL clinically. PMID: 23887020
    41. Levels of serum APRIL are useful biomarkers for disease progression and disease activity in multiple myeloma. PMID: 24141333
    42. APRIL depletion induces cell cycle arrest and apoptosis partly through blocking noncanonical TGF-beta1/ERK. PMID: 23867993
    43. Increased serum expression of APRIL correlates with the development of colorectal neoplasms. PMID: 23792260
    44. Although neither serum BAFF nor APRIL correlated with disease activity in the overall population, elevated serum BAFF and reduced APRIL may be markers of renal and CNS disease in systemic lupus erythematosus patients PMID: 23846230
    45. Our findings indicate TNFSF13 is a prognostic factor in non-small cell lung cancer PMID: 24436270
    46. Both APRIL and B-cell-activating factor (BAFF) regulate spinal cord injury-induced autoimmunity through B-cell maturation antigen (BMCA). PMID: 23088438
    47. increased serum levels of BLyS and APRIL in BD patients supports the notion of a critical role for B cell activation factors in BD, particularly in terms of uveitis and disease activity. PMID: 22752534
    48. Using a capture sequencing strategy, we discovered the B-cell relevant genes IRF8, EBF1, and TNFSF13 as novel targets for IGH deregulation. PMID: 23775715
    49. APRIL protein is upregulated in the serum of patients with opsoclonus-myoclonus syndrome. PMID: 23324534
    50. High serum APRIL is associated with multiple myeloma. PMID: 23768867

    顯示更多

    收起更多

  • 亞細(xì)胞定位：
    Secreted.
  • 蛋白家族：
    Tumor necrosis factor family
  • 組織特異性：
    Expressed at high levels in transformed cell lines, cancers of colon, thyroid, lymphoid tissues and specifically expressed in monocytes and macrophages.
  • 數(shù)據(jù)庫鏈接：

    HGNC: 11928

    OMIM: 604472

    KEGG: hsa:8741

    STRING: 9606.ENSP00000343505

    UniGene: Hs.54673



×
生命科學(xué)計(jì)算平臺(tái)